These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2866025)

  • 1. Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients.
    Ban TA; Guy W; Wilson WH
    Can J Psychiatry; 1985 Oct; 30(6):406-8. PubMed ID: 2866025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of chlorpromazine-induced cutaneous pigmentation following substitution with levomepromazine or other neuroleptics.
    Bloom D; Krishnan B; Thavundayil JX; Lal S
    Acta Psychiatr Scand; 1993 Mar; 87(3):223-4. PubMed ID: 8096668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorpromazine-induced cutaneous pigmentation--effect of replacement with clozapine.
    Lal S; Lal S
    J Psychiatry Neurosci; 2000 May; 25(3):281. PubMed ID: 10863889
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
    Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM
    Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal deposition after high-dose chlorpromazine hydrochloride therapy.
    Webber SK; Domniz Y; Sutton GL; Rogers CM; Lawless MA
    Cornea; 2001 Mar; 20(2):217-9. PubMed ID: 11248834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of chlorpromazine-induced pigmentation with haloperidol substitution.
    Thompson TR; Lal S; Yassa R; Gerstein W
    Acta Psychiatr Scand; 1988 Dec; 78(6):763-5. PubMed ID: 3223334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of graded ocular anterior chamber pigmentation to phenothiazine intake in schizophrenics--quantification procedures.
    Thaler JS; Curinga R; Kiracofe G
    Am J Optom Physiol Opt; 1985 Sep; 62(9):600-4. PubMed ID: 4050962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous and ocular changes associated with the use of chlorpromazine.
    Wolf ME; Richer S; Berk MA; Mosnaim AD
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia and skin pigmentation.
    Ananth J; Yassa R
    Br J Psychiatry; 1982 Aug; 141():194-5. PubMed ID: 6126238
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome.
    Srinivasan AV; Murugappan M; Krishnamurthy SG; Sayeed ZA
    J Neurol Neurosurg Psychiatry; 1990 Jun; 53(6):514-6. PubMed ID: 1974283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drug doses in a schizophrenia inpatient unit.
    Galletly CA
    Aust N Z J Psychiatry; 1992 Dec; 26(4):574-6. PubMed ID: 1362051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of Phenothiazine-produced skin pigmentation: a preliminary report.
    Gibbard BA; Lehmann HE
    Am J Psychiatry; 1966 Sep; 123(3):351-2. PubMed ID: 5917622
    [No Abstract]   [Full Text] [Related]  

  • 15. Physical signs for the General Dental Practitioner. Case 19. Pigmentation disorder.
    Bain S; Hamburger J
    Dent Update; 2004 Nov; 31(9):560. PubMed ID: 15612464
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipsychotic medication: clinical guidelines for maintenance therapy.
    Johnson DA
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic dosing in chronic schizophrenia: a 10-year follow-up.
    Remington GJ; Prendergast P; Bezchlibnyk-Butler KZ
    Can J Psychiatry; 1997 Feb; 42(1):53-7. PubMed ID: 9040924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigmented purpuric eruption associated with injection medroxyprogesterone acetate.
    Tsao H; Lerner LH
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):308-10. PubMed ID: 10906656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flagellated pigmentation caused by bleomycin. Presentation of 2 cases].
    Vicente MA; Iranzo P; Azon A; Mascaro JM; Grau J
    Med Cutan Ibero Lat Am; 1990; 18(2):148-50. PubMed ID: 1699091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of tardive dyskinesia Part I.
    Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Pires P; Villenueve
    Dis Nerv Syst; 1976 Apr; 37(4):210-4. PubMed ID: 3394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.